metoclopramide has been researched along with Hypertension in 80 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both metoclopramide, a selective dopamine type-2 receptor antagonist and partial agonist of 5-hydroxytryptamine 4 receptor, and labetalol, a non-selective β-adrenoreceptor-blocker with weak α1-adrenergic antagonism, exacerbated an acute hypertensive crisis revealing an unrecognised pheochromocytoma in a pregnant patient." | 8.02 | Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency. ( Cabassi, A; Calvi, A; Coghi, P; Cunzi, D; Giunta, A; Negro, A; Palladini, B; Santi, R; Tedeschi, S; Verzicco, I; Volpi, R, 2021) |
| "A central dopaminergic origin has been demonstrated for the bromocriptine-induced tachycardia in conscious, normotensive rats." | 7.71 | Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats. ( Lahlou, S, 2001) |
| "Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain." | 7.69 | Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995) |
| "We studied 5-mg metoclopramide provocation in six pheochromocytomatous patients with different tumor locations, varying secretory patterns and large tumor sizes (> 12 g or equivalently) and in 14 patients with essential hypertension as part of diagnostic work-up, usually after screening with vanillylmandelic acid assay by the colorimetric method." | 7.68 | Diagnostic use of metoclopramide in hypertension caused by pheochromocytoma. ( Hsu, TS; Kuo, CT; Lee, CP, 1993) |
| "The present study aimed to elucidate the role of renal dopaminergic and prostaglandin (PG) systems in renal uric acid metabolism in essential hypertension." | 7.68 | [The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension]. ( Hasegawa, T; Iimura, O; Kikuchi, K; Komura, H; Marusaki, S; Nanba, M; Ohtomo, T; Satoh, N; Suzuki, S; Takada, T, 1991) |
| "Aldosterone responses to posture and the dopamine antagonist, metoclopramide, were studied in seven normotensive controls and 12 patients with essential hypertension." | 7.67 | Enhanced response of plasma aldosterone to metoclopramide in essential hypertension. ( Eshkol, A; Lunenfeld, B; Rosenthal, T; Sowers, JR; Stern, N; Tuck, M, 1984) |
| "Administration of two dopamine antagonists, domperidone and metoclopramide, gave a marked rise in blood pressure with an increase in plasma catecholamines in two patients with pheochromocytoma." | 7.67 | Increase in blood pressure in pheochromocytoma induced by domperidone and metoclopramide. ( Arai, M; Ichikawa, S; Murata, K; Ono, Z, 1985) |
| "A hypertensive crisis associated with evidence of catecholamine release was induced following intravenous administration of 10 mg metoclopramide in a woman with pheochromocytoma and in whom the tyramine test was negative." | 7.67 | Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma. ( Abe, M; Nakamura, M; Nakashima, Y; Orita, Y, 1984) |
| "The catecholamine (CA)-releasing action of metoclopramide (MCP) observed in patients with pheochromocytoma was tested in 20 subjects with essential hypertension and compared with the same effect of glucagon in 10 of them." | 7.67 | Effect of metoclopramide on plasma catecholamine release in essential hypertension. ( Buu, NT; Hamet, P; Kuchel, O; Larochelle, P, 1985) |
| "Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism." | 7.67 | Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985) |
| "Cardiovascular and plasma catecholamine responses to metoclopramide (MCP), a dopamine antagonist, were examined in 5 patients with pheochromocytoma, 12 patients with essential hypertension (EHT) and 9 normotensive (NT) subjects who displayed symptoms suggestive of pheochromocytoma on a constant daily intake of 100 mEq sodium and 80 mEq potassium." | 7.67 | Metoclopramide in the diagnosis of pheochromocytoma. ( Itaya, Y; Kawabe, H; Kondo, K; Saruta, T; Suzuki, H, 1985) |
| " These studies were performed in patients with essential hypertension who were maintained on a constant sodium intake (100 mmol/day), before and after 5 days of treatment with ibopamine, an orally active dopamine analogue." | 7.67 | Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension. ( Ambrosi, B; Ardeleani, G; Ferraris, P; Morganti, A; Quorso, P; Sala, C; Venegoni, P; Zanchetti, A, 1988) |
| "Metoclopramide (MCP) is a commonly used anti-emetic in the emergency department (ED)." | 5.48 | Metoclopramide induced pheochromocytoma crisis. ( Kim, HK; Leonard, JB; Munir, KM, 2018) |
| "Pheochromocytoma is a rare disease that may occur during pregnancy." | 5.30 | Pheochromocytoma in pregnancy manifesting hypertensive crisis induced by metoclopramide. ( Kinoshita, K; Seki, H; Takai, Y, 1997) |
| "The effect of chronic converting enzyme inhibition with enalapril on the PRA, PRL and plasma aldosterone responses to metoclopramide was studied in 10 patients with mild to moderate essential hypertension." | 5.06 | Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition. ( Dupont, AG; Van der Nipen, P; Van Steirteghem, AC; Vanhaelst, L, 1987) |
| "To evaluate the humoral and hemodynamic (both systemic and renal) effects of celiprolol and to assess whether these effects are at least partially due to the activation of dopamine (DA) receptors, 9 out-patients with mild to moderate uncomplicated essential hypertension, without any therapy for at least 3 weeks, received celiprolol (400 mg once daily) and placebo, each for 1 month, according to a double-blind randomized trial pattern." | 5.06 | Systemic and renal hemodynamic effects of celiprolol in essential hypertensives. ( Lucarini, AR; Salvetti, A, 1988) |
| "Both metoclopramide, a selective dopamine type-2 receptor antagonist and partial agonist of 5-hydroxytryptamine 4 receptor, and labetalol, a non-selective β-adrenoreceptor-blocker with weak α1-adrenergic antagonism, exacerbated an acute hypertensive crisis revealing an unrecognised pheochromocytoma in a pregnant patient." | 4.02 | Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency. ( Cabassi, A; Calvi, A; Coghi, P; Cunzi, D; Giunta, A; Negro, A; Palladini, B; Santi, R; Tedeschi, S; Verzicco, I; Volpi, R, 2021) |
| "A central dopaminergic origin has been demonstrated for the bromocriptine-induced tachycardia in conscious, normotensive rats." | 3.71 | Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats. ( Lahlou, S, 2001) |
| "To assess the role of spinal dopamine receptors in mediation of hypotension induced by systemic administration of the dopamine D2 receptor agonist, bromocriptine, conscious deoxycorticosterone acetate (DOCA)-salt hypertensive rats were pretreated with either intravenous (i." | 3.70 | Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors. ( Duarte, GP; Lahlou, S, 1998) |
| "Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain." | 3.69 | Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995) |
| "To investigate the possible role of dopamine, a catecholamine with natriuretic properties, in modulating the escape from the sodium-retaining effects of mineralocorticoids, we submitted six aldosterone-producing adenoma (APA) patients and six low-renin essential hypertensive patients to acute volume expansion by head-out water immersion with or without dopaminergic blockade by metoclopramide." | 3.69 | Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine? ( Coruzzi, P, 1994) |
| "This study was undertaken to clarify the role of dopamine receptor (DA2) on the effects of atrial natriuretic polypeptide(ANP) on blood pressure, plasma and urinary cyclic GMP, and urinary sodium excretion, alpha-human ANP (alpha-hANP) was intravenously administrated to 7 normal subjects and 14 patients with essential hypertension as follows: first a dose of 0." | 3.68 | [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension]. ( Fukuchi, S; Haga, H; Kato, K; Kin, S; Kohno, H; Mori, K; Shigetomi, S; Tanaka, K; Tosaki, H, 1990) |
| "The present study aimed to elucidate the role of renal dopaminergic and prostaglandin (PG) systems in renal uric acid metabolism in essential hypertension." | 3.68 | [The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension]. ( Hasegawa, T; Iimura, O; Kikuchi, K; Komura, H; Marusaki, S; Nanba, M; Ohtomo, T; Satoh, N; Suzuki, S; Takada, T, 1991) |
| "Eleven patients with moderate to severe hypertension were pre-treated with oral labetalol 800-1200 mg/day for one week, prior to receiving two i." | 3.68 | Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients. ( Forte, P; Hernandez Pieretti, O; Luchsinger, A; Martin, G; Mendoza, F; Romero, E; Urbina-Quintana, A; Velasco, M, 1993) |
| "We studied 5-mg metoclopramide provocation in six pheochromocytomatous patients with different tumor locations, varying secretory patterns and large tumor sizes (> 12 g or equivalently) and in 14 patients with essential hypertension as part of diagnostic work-up, usually after screening with vanillylmandelic acid assay by the colorimetric method." | 3.68 | Diagnostic use of metoclopramide in hypertension caused by pheochromocytoma. ( Hsu, TS; Kuo, CT; Lee, CP, 1993) |
| " Nonmodulating hypertension in part is characterized by decreased aldosterone secretion in response to angiotensin II (AII) as well as a decreased natriuretic response to a saline load." | 3.67 | The role of dopamine in nonmodulating hypertension. ( Conlin, PR; Gordon, MS; Hollenberg, NK; Steunkel, CA; Williams, GH, 1989) |
| " To test the hypothesis that LY171555 inhibits in vivo release of DA and its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), from central dopaminergic neurons of the conscious, freely moving rat by activation of presynaptic DA receptors in the central nervous system and that this mechanism may be altered in the desoxycorticosterone acetate (DOCA)/NaCl model of hypertension, we used the in vivo push-pull perfusion method to study the effect of LY171555 on central DA release in normotensive and DOCA/NaCl-hypertensive rats." | 3.67 | Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats. ( Chen, YF; Oparil, S, 1987) |
| " These studies were performed in patients with essential hypertension who were maintained on a constant sodium intake (100 mmol/day), before and after 5 days of treatment with ibopamine, an orally active dopamine analogue." | 3.67 | Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension. ( Ambrosi, B; Ardeleani, G; Ferraris, P; Morganti, A; Quorso, P; Sala, C; Venegoni, P; Zanchetti, A, 1988) |
| "To investigate whether dopamine plays a role in the regulation of aldosterone secretion during long-term blockade of the renin-angiotensin system, we studied the effect of metoclopramide, a competitive antagonist of dopamine, in 6 patients with essential hypertension chronically treated with the angiotensin converting enzyme inhibitor enalapril." | 3.67 | Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor. ( Brunner, HR; Gomez, HJ; Nussberger, J; Schaller, MD; Waeber, B, 1986) |
| "Hyperresponsiveness of plasma aldosterone to metoclopramide (MCP) was found in the patients with secondary aldosteronism." | 3.67 | [Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide]. ( Iwasaki, Y, 1987) |
| "To evaluate the role of the renal dopaminergic system on renal water-sodium metabolism patients with essential hypertension (EHT), urinary excretion of dopamine, urinary excretion of sodium (UNaV) and fractional excretion of sodium (FENa) were all investigated before and after the administration of dopamine (3 micrograms/kg/min, intravenous infusion for 60 minutes), dopamine antagonist, metoclopramide (8 mg/m2 BSA, intravenous injection) or mild sodium loading in both normotensive subjects and benign EHT." | 3.67 | The pathophysiological role of renal dopaminergic activity in patients with essential hypertension. ( Aoki, K; Hasegawa, T; Iimura, O; Kikuchi, K; Kobayakawa, H; Komura, H; Nishimura, M; Nozawa, A; Shibata, S; Yamaji, I, 1987) |
| "01) was observed in ten patients with untreated essential hypertension (148 +/- 4/97 +/- 1 mmHg, means +/- SE) compared with ten healthy normotensive men of the same age (124 +/- 3/78 +/- 2 mmHg) after administration of metoclopramide, a competitive dopamine antagonist." | 3.67 | Central dopaminergic control of prolactin in essential hypertension. ( Aakesson, I; Eide, I; Hjermann, I; Kjeldsen, SE; Normann, N; Os, I; Westheim, A, 1986) |
| "Aldosterone responses to posture and the dopamine antagonist, metoclopramide, were studied in seven normotensive controls and 12 patients with essential hypertension." | 3.67 | Enhanced response of plasma aldosterone to metoclopramide in essential hypertension. ( Eshkol, A; Lunenfeld, B; Rosenthal, T; Sowers, JR; Stern, N; Tuck, M, 1984) |
| "Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism." | 3.67 | Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985) |
| "We studied natriuresis during central hypervolaemia by immersing eight normal subjects and eight patients with uncomplicated essential hypertension up to the neck in water, either in the absence (study 1) or presence (study 2) of dopamine blockade by metoclopramide." | 3.67 | Dopamine blockade abolishes the exaggerated natriuresis of essential hypertension. ( Biggi, A; Coruzzi, P; Musiari, L; Novarini, A; Ravanetti, C, 1987) |
| "Administration of two dopamine antagonists, domperidone and metoclopramide, gave a marked rise in blood pressure with an increase in plasma catecholamines in two patients with pheochromocytoma." | 3.67 | Increase in blood pressure in pheochromocytoma induced by domperidone and metoclopramide. ( Arai, M; Ichikawa, S; Murata, K; Ono, Z, 1985) |
| "A hypertensive crisis associated with evidence of catecholamine release was induced following intravenous administration of 10 mg metoclopramide in a woman with pheochromocytoma and in whom the tyramine test was negative." | 3.67 | Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma. ( Abe, M; Nakamura, M; Nakashima, Y; Orita, Y, 1984) |
| "Cardiovascular and plasma catecholamine responses to metoclopramide (MCP), a dopamine antagonist, were examined in 5 patients with pheochromocytoma, 12 patients with essential hypertension (EHT) and 9 normotensive (NT) subjects who displayed symptoms suggestive of pheochromocytoma on a constant daily intake of 100 mEq sodium and 80 mEq potassium." | 3.67 | Metoclopramide in the diagnosis of pheochromocytoma. ( Itaya, Y; Kawabe, H; Kondo, K; Saruta, T; Suzuki, H, 1985) |
| "The catecholamine (CA)-releasing action of metoclopramide (MCP) observed in patients with pheochromocytoma was tested in 20 subjects with essential hypertension and compared with the same effect of glucagon in 10 of them." | 3.67 | Effect of metoclopramide on plasma catecholamine release in essential hypertension. ( Buu, NT; Hamet, P; Kuchel, O; Larochelle, P, 1985) |
| "Some investigators have reported that plasma prolactin levels are elevated in hypertensive men and that both their hyperprolactinemia and hypertension were controlled by bromocriptine, a dopamine agonist." | 3.66 | Is normoreninemic essential hypertension caused by disordered central dopaminergic regulation? ( Goto, M; Higaki, J; Kanda, T; Kumahara, Y; Maruyama, A; Naka, T; Ogihara, T; Onishi, T, 1980) |
| "Metoclopramide (MCP) is a commonly used anti-emetic in the emergency department (ED)." | 1.48 | Metoclopramide induced pheochromocytoma crisis. ( Kim, HK; Leonard, JB; Munir, KM, 2018) |
| "Pheochromocytoma is a rare disease that may occur during pregnancy." | 1.30 | Pheochromocytoma in pregnancy manifesting hypertensive crisis induced by metoclopramide. ( Kinoshita, K; Seki, H; Takai, Y, 1997) |
| "Nonmodulating hypertension is characterized, in part, by a decreased aldosterone response to AII, raising the possibility that an increased dopaminergic inhibition of aldosterone secretion underlies the adrenal defect in nonmodulating hypertension." | 1.28 | Dopamine and nonmodulating hypertension. ( Conlin, PR; Gordon, MS; Hollenberg, NK; Stuenkel, CA; Williams, GH, 1990) |
| "Pretreatment with metoclopramide (20 mg/kg) or SCH 23390 (30 micrograms/kg), a new selective dopamine-1 antagonist, significantly attenuated the vasodilator responses to fenoldopam in all three vascular beds." | 1.27 | Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats. ( Lappe, RW; Todt, JA; Wendt, RL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 51 (63.75) | 18.7374 |
| 1990's | 23 (28.75) | 18.2507 |
| 2000's | 2 (2.50) | 29.6817 |
| 2010's | 3 (3.75) | 24.3611 |
| 2020's | 1 (1.25) | 2.80 |
| Authors | Studies |
|---|---|
| Negro, A | 1 |
| Verzicco, I | 1 |
| Tedeschi, S | 1 |
| Santi, R | 1 |
| Palladini, B | 1 |
| Calvi, A | 1 |
| Giunta, A | 1 |
| Cunzi, D | 1 |
| Coghi, P | 1 |
| Volpi, R | 1 |
| Cabassi, A | 1 |
| Leonard, JB | 1 |
| Munir, KM | 1 |
| Kim, HK | 1 |
| Gur-Ozmen, S | 1 |
| Karahan-Ozcan, R | 1 |
| Donatelli, NS | 1 |
| Somes, J | 1 |
| Wu, KD | 1 |
| Chen, YM | 1 |
| Chu, TS | 1 |
| Chueh, SC | 1 |
| Tsai, GC | 1 |
| Tseng, YZ | 1 |
| Hsieh, BS | 1 |
| Stern, N | 2 |
| Eshkol, A | 2 |
| Lunenfeld, B | 2 |
| Rosenthal, T | 2 |
| Jäättelä, A | 1 |
| Mäki, O | 1 |
| Nagahama, S | 1 |
| Chen, YF | 2 |
| Oparil, S | 2 |
| Shikuma, R | 2 |
| Kambara, S | 2 |
| Yoshimura, M | 2 |
| Takashina, R | 2 |
| Yamasaki, H | 1 |
| Takeda, K | 2 |
| Takahashi, H | 2 |
| Ijichi, H | 2 |
| Sowers, JR | 3 |
| Tuck, M | 1 |
| Minuz, P | 1 |
| Gangi, F | 1 |
| Degan, M | 1 |
| Lechi, C | 1 |
| Delva, P | 1 |
| Lechi, A | 1 |
| Kawabe, H | 2 |
| Kondo, K | 2 |
| Saruta, T | 2 |
| Vogelzang, NJ | 1 |
| Abe, M | 1 |
| Orita, Y | 1 |
| Nakashima, Y | 1 |
| Nakamura, M | 1 |
| Ogihara, T | 1 |
| Maruyama, A | 1 |
| Naka, T | 1 |
| Higaki, J | 1 |
| Kanda, T | 1 |
| Goto, M | 1 |
| Onishi, T | 1 |
| Kumahara, Y | 1 |
| Lengyel, AM | 1 |
| Vieira, JG | 1 |
| Chacra, AR | 1 |
| Abucham-Filho, JZ | 1 |
| Lima, MP | 1 |
| Ribeiro, AB | 1 |
| Ramos, OL | 1 |
| Sollars, EG | 1 |
| Tuck, ML | 1 |
| Asp, ND | 1 |
| Barrett, JD | 1 |
| Sambhi, MP | 1 |
| Sheridan, C | 1 |
| Chandra, P | 1 |
| Jacinto, M | 1 |
| Greenwald, ES | 1 |
| Coruzzi, P | 3 |
| Hsu, TS | 1 |
| Lee, CP | 1 |
| Kuo, CT | 1 |
| Martin, G | 3 |
| Forte, P | 4 |
| Luchsinger, A | 6 |
| Mendoza, F | 2 |
| Urbina-Quintana, A | 2 |
| Hernandez Pieretti, O | 2 |
| Romero, E | 3 |
| Velasco, M | 9 |
| Hernandez, O | 1 |
| Grilli, M | 2 |
| Morales, E | 2 |
| Corujo, M | 1 |
| Valery, J | 1 |
| Naruse, M | 1 |
| Naruse, K | 1 |
| Yoshimoto, T | 1 |
| Tanaka, M | 1 |
| Tanabe, A | 1 |
| Imaki, T | 1 |
| Shibasaki, T | 1 |
| Demura, R | 1 |
| Demura, H | 1 |
| Rossi, G | 1 |
| Manunta, P | 1 |
| Hamlyn, JM | 1 |
| Pavan, E | 1 |
| De Toni, R | 1 |
| Semplicini, A | 1 |
| Pessina, AC | 1 |
| Freestone, S | 1 |
| Duffield, J | 1 |
| Lee, MR | 1 |
| Blanco, M | 3 |
| Jelambi, I | 2 |
| Pérez, G | 2 |
| Gómez, J | 3 |
| Franco, T | 1 |
| Hurtado, N | 2 |
| Takai, Y | 1 |
| Seki, H | 1 |
| Kinoshita, K | 1 |
| Lahlou, S | 2 |
| Duarte, GP | 1 |
| Negrín, C | 1 |
| Blanco, G | 1 |
| Rodriguez, M | 1 |
| Torres, M | 1 |
| Vásquez, M | 1 |
| Alcalá, I | 1 |
| Vargas, R | 1 |
| Carrillo, M | 1 |
| Bravo, C | 1 |
| Gomez, H | 1 |
| Collet, H | 1 |
| Plouin, PF | 1 |
| Menard, J | 1 |
| Corvol, P | 1 |
| Agabiti-Rosei, E | 2 |
| Alicandria, CL | 1 |
| Corea, L | 2 |
| Sever, PS | 1 |
| Brown, RD | 1 |
| Wisgerhof, M | 1 |
| Carpenter, PC | 1 |
| Brown, G | 1 |
| Jiang, NS | 1 |
| Kao, P | 1 |
| Hegstad, R | 1 |
| Alicandri, C | 1 |
| Fariello, R | 1 |
| Miele, N | 1 |
| Rampton, DS | 1 |
| Mori, K | 2 |
| Satoh, N | 1 |
| Kikuchi, K | 2 |
| Hasegawa, T | 2 |
| Komura, H | 2 |
| Suzuki, S | 1 |
| Ohtomo, T | 1 |
| Takada, T | 1 |
| Nanba, M | 1 |
| Marusaki, S | 1 |
| Iimura, O | 2 |
| Matsuoka, H | 1 |
| Fukui, K | 1 |
| Dan, Y | 1 |
| Ishimitsu, T | 1 |
| Hirata, Y | 1 |
| Kimura, K | 1 |
| Sugimoto, T | 1 |
| Ishii, M | 1 |
| Kangawa, K | 1 |
| Matsuo, H | 1 |
| Shigetomi, S | 1 |
| Kohno, H | 1 |
| Tosaki, H | 1 |
| Kato, K | 1 |
| Tanaka, K | 1 |
| Haga, H | 1 |
| Kin, S | 1 |
| Fukuchi, S | 1 |
| Zacharieva, S | 1 |
| Stoeva, I | 1 |
| Matrozov, P | 1 |
| Andonova, K | 1 |
| Williams, GH | 2 |
| Gordon, MS | 2 |
| Stuenkel, CA | 1 |
| Conlin, PR | 2 |
| Hollenberg, NK | 2 |
| Montanari, A | 1 |
| Ragni, G | 1 |
| Vallisa, D | 1 |
| Colla, R | 1 |
| Serventi, M | 1 |
| Novarini, A | 2 |
| Lande, K | 1 |
| Os, I | 3 |
| Kjeldsen, SE | 3 |
| Westheim, A | 3 |
| Hjermann, I | 3 |
| Eide, I | 3 |
| Gjesdal, K | 1 |
| Miura, Y | 3 |
| Takahashi, M | 2 |
| Sano, N | 2 |
| Ohzeki, T | 2 |
| Meguro, Y | 2 |
| Sugawara, T | 2 |
| Noshiro, T | 2 |
| Watanabe, H | 2 |
| Shimizu, K | 2 |
| Abe, K | 1 |
| Steunkel, CA | 1 |
| Słowińska-Srzednicka, J | 1 |
| Puciłowska, J | 1 |
| Zgliczyński, S | 1 |
| Sato, T | 1 |
| Igarashi, N | 1 |
| Minami, S | 1 |
| Okabe, T | 1 |
| Hashimoto, H | 1 |
| Hasui, M | 1 |
| Kato, E | 1 |
| Bernini, GP | 2 |
| Lucarini, AR | 3 |
| Franchi, F | 1 |
| Salvetti, A | 3 |
| Lappe, RW | 1 |
| Todt, JA | 1 |
| Wendt, RL | 1 |
| Dupont, AG | 3 |
| Vanderniepen, P | 2 |
| Volckaert, A | 2 |
| Smitz, J | 2 |
| Vansteirteghem, AC | 2 |
| Six, RO | 2 |
| Leonetti, G | 1 |
| Rupoli, L | 1 |
| Sangiorgio, P | 1 |
| Mauro, M | 1 |
| Di Stratis, P | 1 |
| Zanchetti, A | 2 |
| Sala, C | 1 |
| Morganti, A | 1 |
| Ferraris, P | 1 |
| Ardeleani, G | 1 |
| Venegoni, P | 1 |
| Quorso, P | 1 |
| Ambrosi, B | 1 |
| Alföldi, A | 2 |
| Kárteszi, M | 1 |
| Simkó, K | 1 |
| Farsang, C | 2 |
| Waeber, B | 1 |
| Nussberger, J | 1 |
| Schaller, MD | 1 |
| Gomez, HJ | 1 |
| Brunner, HR | 1 |
| Mantero, F | 1 |
| Rocco, S | 1 |
| Opocher, G | 1 |
| Boscaro, M | 1 |
| Fallo, F | 1 |
| D'Agostino, D | 1 |
| Iwasaki, Y | 1 |
| Van der Nipen, P | 1 |
| Van Steirteghem, AC | 1 |
| Vanhaelst, L | 1 |
| Hanew, K | 1 |
| Musiari, L | 1 |
| Biggi, A | 1 |
| Ravanetti, C | 1 |
| Yamaji, I | 1 |
| Shibata, S | 1 |
| Nishimura, M | 1 |
| Nozawa, A | 1 |
| Aoki, K | 1 |
| Kobayakawa, H | 1 |
| Normann, N | 1 |
| Aakesson, I | 2 |
| Jungmann, E | 1 |
| Wirth, K | 1 |
| Rosak, C | 1 |
| Althoff, PH | 1 |
| Norman, N | 1 |
| Enger, E | 1 |
| Witzgall, H | 1 |
| Lorenz, R | 1 |
| von Werder, K | 1 |
| Weber, PC | 1 |
| Yamazaki, H | 1 |
| Kuchel, O | 1 |
| Buu, NT | 1 |
| Hamet, P | 1 |
| Larochelle, P | 1 |
| Ichikawa, S | 1 |
| Ono, Z | 1 |
| Arai, M | 1 |
| Murata, K | 1 |
| Itaya, Y | 1 |
| Suzuki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Controlled Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis[NCT02493049] | Phase 2 | 17 participants (Actual) | Interventional | 2015-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for metoclopramide and Hypertension
| Article | Year |
|---|---|
Beers list: what's NOT on "tap" for the older adult.
Topics: Aged, 80 and over; Antiemetics; Antihypertensive Agents; Arthritis; Chlorpropamide; Confusion; Diabe | 2013 |
Aldosterone, calcium, and hypertension.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Calcium; Calcium Channel Blockers | 1986 |
16 trials available for metoclopramide and Hypertension
| Article | Year |
|---|---|
Comparison of long-acting propranolol and conventional metoprolol in the treatment of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Hea | 1983 |
Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Bromocriptine; Dopamine Antagonists; Dopamine | 1995 |
Dopaminergic influence on the cardiovascular response to exercise in normotensive and hypertensive subjects.
Topics: Adult; Blood Pressure; Cross-Over Studies; Domperidone; Dopamine; Dopamine Antagonists; Exercise; Fe | 1995 |
Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Dopamine; Dopamine Antagonists; Female; | 1995 |
Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Bromocriptine; Case-Control Studies; Cr | 1998 |
Metoclopramide enhances labetalol-induced antihypertensive effect during handgrip in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Female; Hand Str | 1998 |
Dopaminergic influence on cardiovascular responses to exercise stress in hypertensive subjects.
Topics: Blood Pressure; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; E | 1997 |
Atrial natriuretic peptide inhibits the aldosterone response to metoclopramide in patients with glomerular disease and essential hypertension.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerulonephritis; Heart Rat | 1991 |
Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Domperidone; Female; Humans; Hydrocortisone; Hypert | 1988 |
Fenoldopam: effect on aldosterone secretion.
Topics: Aldosterone; Benzazepines; Double-Blind Method; Fenoldopam; Humans; Hypertension; Metoclopramide; Mi | 1986 |
Effect of fenoldopam on the aldosterone response to metoclopramide in man.
Topics: Aldosterone; Benzazepines; Clinical Trials as Topic; Double-Blind Method; Fenoldopam; Humans; Hypert | 1986 |
Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Celiprolol; Clinical Trials as Topic; D | 1988 |
Dopaminergic-opioidergic interaction is reflected by changes in pituitary hormone secretion in patients with essential hypertension.
Topics: beta-Endorphin; Dopamine; Female; Humans; Hypertension; Male; Metoclopramide; Naloxone; Physical Exe | 1988 |
Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Hum | 1987 |
[Increased endogenous dopamine activity in diabetes mellitus. Inhibition of plasma renin activity, aldosterone and prolactin secretion].
Topics: Aged; Aldosterone; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dopamine; Humans; Hypertensi | 1986 |
Metoclopramide decreases baroreflex sensitivity in patients with essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Dopamine; Female; Heart Rate; Humans; Hypertension; Kinetics; Mal | 1987 |
62 other studies available for metoclopramide and Hypertension
| Article | Year |
|---|---|
Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cesarean Section; Female; Humans; Hypertension; Infan | 2021 |
Metoclopramide induced pheochromocytoma crisis.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antiemetics; Emergency Medical Services; Female; Head | 2018 |
Factors Associated with Insulin Resistance in Women with Migraine: A Cross-Sectional Study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Blood Pressure; Body Composition; Bod | 2019 |
Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Diet, Sodium-R | 2002 |
Prolactin secretion in essential hypertension.
Topics: Adult; Humans; Hypertension; Male; Metoclopramide; Middle Aged; Natriuresis; Posture; Potassium; Pro | 1983 |
Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Bromocriptine; Depression, Chemical; Domperidone; Epin | 1984 |
[Dopaminergic modulation of salt sensitivity in essential hypertension].
Topics: Aldosterone; Catecholamines; Diet, Sodium-Restricted; Dopamine; Female; Humans; Hypertension; Male; | 1984 |
Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
Topics: Adult; Aldosterone; Humans; Hypertension; Male; Metoclopramide; Middle Aged; Posture; Potassium; Ren | 1984 |
[The effect of dopaminergic stimulation and inhibition on the urinary excretion of aldosterone and kallikrein in spontaneously hypertensive rats].
Topics: Aldosterone; Animals; Bromocriptine; Dopamine; Hypertension; Kallikreins; Male; Metoclopramide; Natr | 1983 |
Effect of the intracerebroventricular injection of dopamine on blood pressure in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Dopamine; Dopamine Antagonists; Dose-Response Relatio | 1983 |
Hypertension after metoclopramide.
Topics: Cisplatin; Humans; Hypertension; Metoclopramide | 1983 |
Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Catecholamines; Female; Humans; Hypertension; Metoclopramide; Middle Aged; | 1984 |
Is normoreninemic essential hypertension caused by disordered central dopaminergic regulation?
Topics: Bromocriptine; Depression, Chemical; Hormones; Humans; Hypertension; Male; Metoclopramide; Middle Ag | 1980 |
Dynamic evaluation of prolactin secretion in essential hypertension: evidence against hypothalamic-pituitary dopaminergic dysfunction.
Topics: Adult; Humans; Hypertension; Levodopa; Male; Metoclopramide; Prolactin; Renin; Sleep; Thyrotropin-Re | 1982 |
Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat.
Topics: Aldosterone; Animals; Blood Pressure; Dopamine Antagonists; Hypertension; Levodopa; Male; Metoclopra | 1980 |
Dopaminergic modulation of renin release.
Topics: Animals; Blood Pressure; Dopamine; Dopamine Antagonists; Hypertension; Levodopa; Male; Metoclopramid | 1981 |
Transient hypertension after high doses of metoclopramide.
Topics: Female; Humans; Hypertension; Metoclopramide; Middle Aged | 1982 |
Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Topics: Adenoma; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dopamine; Female | 1994 |
Diagnostic use of metoclopramide in hypertension caused by pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Epinephrine; Female; Humans; Hypertension; Male; Metoclopramide; Mid | 1993 |
Dopamine-induced antihypertensive effects and plasma insulin rise are blocked by metoclopramide in labetalol-treated patients.
Topics: Blood Glucose; Blood Pressure; Dopamine; Dopamine Antagonists; Female; Humans; Hypertension; Infusio | 1994 |
Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients.
Topics: Blood Glucose; Blood Pressure; Dopamine; Female; Heart Rate; Humans; Hypertension; Infusions, Intrav | 1993 |
Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
Topics: Blood Glucose; Blood Pressure; Domperidone; Dopamine; Dopamine Antagonists; Heart; Heart Rate; Human | 1993 |
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Topics: Aldosterone; Blood Pressure; Dihydroergotoxine; Dopamine Agonists; Dopamine Antagonists; Female; Hum | 1995 |
Pressor effect of metoclopramide in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Antiemetics; Female; Humans; Hypertension; Metoclopramide; Pheochrom | 1996 |
The effect of intravenous metoclopramide on blood pressure in normotensive and hypertensive subjects.
Topics: Adult; Blood Pressure; Dopamine Antagonists; Female; Heart Rate; Humans; Hypertension; Infusions, In | 1996 |
Pheochromocytoma in pregnancy manifesting hypertensive crisis induced by metoclopramide.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Antiemetics; Female; Humans; Hypertens | 1997 |
Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bromocriptine; Desoxycorticosterone; | 1998 |
Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Aorta, Abdominal; Blood Pressure; Bradycardia; Bromocriptine; Desoxycorticosterone; Domperi | 2001 |
Hypertensive crisis in patient with phaeochromocytoma given metoclopramide.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Humans; Hypertension; Metoclopramide; Pheochromocytoma; Sul | 1976 |
Hypertensive crisis in patients with phaeochromocytoma given metoclopramide.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Female; Humans; Hypertension; Male; Metoclopramide; | 1977 |
Hypertensive crisis in patients with phaeochromocytoma given metoclopramide.
Topics: Adrenal Gland Neoplasms; Humans; Hypertension; Metoclopramide; Pheochromocytoma | 1977 |
Adrenal sensitivity to angiotensin II and undiscovered aldosterone stimulating factors in hypertension.
Topics: Adrenal Glands; Adult; Aldosterone; Dexamethasone; Female; Humans; Hyperaldosteronism; Hypertension; | 1979 |
[Arterial pressure and plasma catecholamines after metoclopramide administration in normal and hypertensive subjects].
Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Catecholamines; Female; Humans; Hypertension; Hypert | 1977 |
Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline.
Topics: Acute Disease; Amitriptyline; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Human | 1977 |
[The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Cyclic GMP; Dopamin | 1991 |
[The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension].
Topics: Adult; Aged; Creatinine; Dopamine; Dopamine Antagonists; Female; Humans; Hypertension; Indomethacin; | 1991 |
[The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dopamine Antagonists; Humans; Hy | 1990 |
Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
Topics: Acromegaly; Adult; Aldosterone; Dopamine; Female; Humans; Hypertension; Injections, Intravenous; Mal | 1990 |
Dopamine and nonmodulating hypertension.
Topics: Adrenal Glands; Aldosterone; Blood Pressure; Diet; Dopamine; Humans; Hypertension; Metoclopramide; P | 1990 |
Dopaminergic modulation of acute renal effects of nicardipine.
Topics: Blood Pressure; Dopamine; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Metoclopra | 1990 |
Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
Topics: beta-Thromboglobulin; Blood Platelets; Dopamine; Humans; Hypertension; Infusions, Intravenous; Male; | 1989 |
[Catecholamines in hypertension: studies on plasma free dopamine concentration in patients with various types of hypertension].
Topics: Dopamine; Humans; Hypertension; Metoclopramide; Sodium, Dietary | 1989 |
Plasma free dopamine in human hypertension.
Topics: Diet; Dopamine; Humans; Hypertension; Methods; Metoclopramide; Reference Values; Sodium | 1989 |
The role of dopamine in nonmodulating hypertension.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Dopamine; Dose-Response | 1989 |
Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion.
Topics: Acromegaly; Adrenocorticotropic Hormone; Adult; Aldosterone; Cosyntropin; Female; Humans; Hypertensi | 1987 |
Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge.
Topics: Adolescent; Adrenocorticotropic Hormone; Arginine Vasopressin; Child, Preschool; Clonidine; Dinopros | 1988 |
Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Fenoldopam; Heart Rate; Hypertension; Male; Metoclopramide; R | 1986 |
Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filt | 1986 |
Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography; Corpus Striatum; Desoxycorticosterone; Dopa | 1987 |
Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
Topics: Aldosterone; Atrial Natriuretic Factor; Deoxyepinephrine; Dopamine; Humans; Hypertension; Metoclopra | 1988 |
Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme | 1986 |
[Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Diuretics; Dopamine; Female; Humans; Hyperaldostero | 1987 |
[Effects of high sodium diet on dopaminergic mechanism in normal and hypertensive subjects].
Topics: Adult; Aldosterone; Blood Pressure; Dopamine; Epinephrine; Heart Rate; Humans; Hypertension; Metoclo | 1988 |
Dopamine blockade abolishes the exaggerated natriuresis of essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Creatinine; Humans; Hypertension; Immersion; Male; Metoclopramid | 1987 |
The pathophysiological role of renal dopaminergic activity in patients with essential hypertension.
Topics: Adult; Dopamine; Dopamine Antagonists; Female; Humans; Hypertension; Infusions, Intravenous; Injecti | 1987 |
Central dopaminergic control of prolactin in essential hypertension.
Topics: Adult; Dopamine; Dopamine Antagonists; Humans; Hypertension; Male; Metoclopramide; Norepinephrine; P | 1986 |
Decreased central dopaminergic activity in essential hypertension.
Topics: Adult; Arginine Vasopressin; Dopamine; Epinephrine; Forearm; Heart Rate; Humans; Hypertension; Male; | 1987 |
Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Corticosterone; Depres | 1985 |
Dopaminergic modulation of salt sensitivity in patients with essential hypertension.
Topics: Aged; Aldosterone; Blood Pressure; Dopamine; Dopamine Antagonists; Epinephrine; Female; Humans; Hype | 1986 |
Effect of metoclopramide on plasma catecholamine release in essential hypertension.
Topics: Adult; Blood Pressure; Catecholamines; Catheterization; Dopamine; Drug Evaluation; Epinephrine; Fema | 1985 |
Increase in blood pressure in pheochromocytoma induced by domperidone and metoclopramide.
Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Domperidone; Epinephrine; Female; Humans; Hypertensi | 1985 |
Metoclopramide in the diagnosis of pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; | 1985 |